About 80% of AD patients are insulin resistant or have T2DM de la Monte, 2014; additionally, T2DM patients have a higher risk of up to 73% dementia than healthy controls do (Koekkoek et al., 2015). This evidence concerns the gene INS and Alzheimer disease.